About Narus Biotechnologies
Narus Biotechnologies is a company based in San Francisco (United States) founded in 2015 was acquired by Cofactor Genomics in February 2016. Narus Biotechnologies operates in a competitive market with competitors including Prenetics, Veracyte, Cofactor Genomics, Cytox and ADx NeuroSciences, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Cofactor Genomics
(Feb 02, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Narus Biotechnologies
Detailed funding history for Narus Biotechnologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Narus Biotechnologies
Narus Biotechnologies has secured backing from 1 investor. Prominent investors backing the company include Cofactor Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diagnostic assays are developed using RNA sequencing technology.
|
Locked | Locked | Locked |
Investor details for Narus Biotechnologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Narus Biotechnologies
Investment portfolio details for Narus Biotechnologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Narus Biotechnologies
Detailed financials for Narus Biotechnologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Narus Biotechnologies Comparisons
Peer comparison for Narus Biotechnologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Narus Biotechnologies
Narus Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Veracyte, Cofactor Genomics, Cytox and ADx NeuroSciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
|
| Locked | Locked | Locked |
Diagnostic assays are developed using RNA sequencing technology.
|
|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
Detailed competitors of Narus Biotechnologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Narus Biotechnologies
Complete news archive for Narus Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narus Biotechnologies
Narus Biotechnologies was founded in 2015.
Narus Biotechnologies is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Narus Biotechnologies was founded in 2015 in San Francisco, United States, within the biotechnology sector. RNA-based diagnostic tests for neurological disorders were developed using a proprietary platform that incorporated custom biomarker panels and bioinformatic analysis. This supported physicians in selecting treatment regimens for conditions including multiple sclerosis, Alzheimers, and Parkinsons disease. The company was acquired by Cofactor Genomics in February 2016 for an undisclosed amount.
Narus Biotechnologies has 1 investor. Key investors include Cofactor Genomics.